Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Free radical formation describes the chemical processes by which neutral atoms or molecules acquire unpaired electrons—most often during normal aerobic metabolism (notably in mitochondria), inflammation (via phagocytic respiratory burst), exposure to radiation, chemicals, and certain drugs. Free radicals (notably ROS and RNS) play dual roles in biology: at moderate concentrations, they are involved in signaling and host defense, but when formation exceeds detoxification, they damage biomolecules including nucleic acids, proteins, and lipids, contributing to diseases such as cancer, cardiovascular disorders, neurodegeneration, and aging. Interventions typically target outcomes of free radical formation (oxidative damage), rather than the process itself[1][3][4][8].
Most drugs or compounds act as free radical scavengers (neutralization via electron donation or chain-breaking), metal chelation (preventing Fenton reaction), or induction of endogenous antioxidant systems
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Free radical formation.